Dr. Paget was the Physician-in-Chief and Chairman of the Division of Rheumatology at Hospital For Special Surgery and the Joseph P. Routh Professor of Medicine and Rheumatic Disease at the Weill Medical College of Cornell University and the New York Presbyterian Hospital for fifteen years and is now the Physician-in-Chief Emeritus. As Chair, he developed and ran a world-class rheumatology division of 46 physicians, scientists and clinician-scholar educators who were focused on clinical, perioperative and consultative care throughout HSS and the York Avenue institutions, basic, translational and clinical and drug trials research and musculoskeletal education to medical students, residents and fellows.
During his time at the NIH and upon arriving at HSS in 1975, his basic immunologic research focused on defining the immunopathogenesis of rheumatoid arthritis. As an Associate Director of an NIH-funded Cornell Multipurpose Arthritis Center, he focused his clinical and translational research on the areas of steroid-induced osteoporosis, systemic vasculitides, rheumatoid arthritis, joint replacements and hip fractures. Most recently, Dr. Paget was a director of the Mary Kirkland Center for Lupus Research at HSS and on the Board of Directors of the Lupus Clinical Trials Consortium and his investigation was directed at attaining a broader understanding of premature atherosclerosis in autoimmune disorders.
He was a Member of the Board of Directors of the American Board of Internal Medicine and the Co-Chair of the rheumatology subspecialty Board and is currently on its rheumatology subspecialty Board. He has been a member of the Board of Directors of the Research and Education Foundation of the American College of Rheumatology and the Chair of its Development Advisory Council. He was recently honored by receiving the American College of Rheumatology’s Master designation and Distinguished Clinical Scholar award. He was a longstanding member of the Board of Trustees of the New York Arthritis Foundation.
Dr. Paget received his MD degree from Downstate Medical Center, did his residency in Internal Medicine at Johns Hopkins and was a Clinical Associate at the National Institute of Arthritis, Musculoskleletal and Skin diseases.
Dr. Paget has both national and international recognition as a Master Clinician in a broad range of inflammatory and autoimmune disorders. As a Clinician-Scholar Educator he has had a significant impact upon rheumatology education and is currently the Director of the HSS Rheumatology Academy of Medical Educators.
Systemic Lupus Erythematosus
Mixed Connective Tissue disease
Adult-onset Still's disease
Granulomatosis with polyangiitis (Wegener's Granulomatosis)Spondyloarthritis
Churg Strauss Vasculitis
Giant Cell Arteritis/Polymyalgia Rheumatica
Psoriatic arthritisOsteoathritis, general and spine
Arthritis associated with Crohn's disease and Ulcerative colitis
Reactive Arthritis/Reiter's syndrome
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Paget as of March 12, 2013.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.
Van Boxel JA, Paget SA. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med 1975;293(11):517-20.
Healey JH, Paget SA, Williams-Russo P, et al. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica. Calcif Tissue Int 1996;58(2):73-80.
Horton R, Peterson MG, Powell S, Engelhard E, Paget SA. Users evaluate LupusLine, a telephone peer counseling service. Arthritis Care Res 1997;10(4):257-63.
36. Yee AM, Hotchkiss RN, Paget SA. Adventitial stripping: a digit saving procedure in refractory Raynaud's phenomenon. J Rheumatol 1998;25(2):269-76.
Spiera RF, Mitnick HJ, Kupersmith M, et al. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 2001;19(5):495-501.
Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349(25):2399-406.
Spiera RF, Kupersmith M, Paget S, Spiera H. Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al. Arthritis Rheum 2003;48(4):1159-60; author reply 60-1.
Danoff-Burg S, Revenson TA, Trudeau KJ, Paget SA. Unmitigated communion, social constraints, and psychological distress among women with rheumatoid arthritis. J Pers 2004;72(1):29-46.
Roman MJ, Devereux RB, Schwartz JE, et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 2005;46(1):194-9.
Mancuso CA, Rincon M, Sayles W, Paget SA. Longitudinal study of negative workplace events among employed rheumatoid arthritis patients and healthy controls. Arthritis Rheum 2005;53(6):958-64
Roman MJ, Moeller E, Davis A, Paget SA, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006;144(4):249-56.
Mancuso CA, Rincon M, Sayles W, Paget SA. Psychosocial variables and fatigue: a longitudinal study comparing individuals with rheumatoid arthritis and healthy controls. J Rheumatol 2006;33(8):1496-502.
Farzaneh-Far A, Roman MJ, Lockshin MD, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 2006;54(12):3918-25.
McIlvane JM, Schiaffino KM, Paget SA. Age differences in the pain-depression link for women with osteoarthritis Functional Impairment and Personal Control as Mediators. Womens Health Issues 2007;17(1):44-51
Allegrante JP, Peterson MG, Cornell CN, MacKenzie RC, Robbins L, Horton R, Ganz SB, Ruchlin HS, Russo PW, Paget SA, et al. Methodological Challenges of Multiple-Component Intervention : Lessons Learned from a Randomized Controlled Trial of Functional Recovery After Hip Fracture. HSS J. 2007. 3 63-70
Klareskog L, Catrina AI, Paget S. Seminar: Rheumatoid Arthritis. Lancet. 2009;373 (9664) 659-72
Berman JR, Lazaro D, Fields T, Paget SA et al The New York City Rheumatology Objective Structure Clinical Examination: Five-year data demonstrates its validity, usefulness as a unique rating tool, objectivity and sensitivity to change. Arthritis Rheumatism 2009; 61: 1686-93.
Charavarty SD, Yee AF, Paget SA. Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies. J Allergy Clin Immunol. 2011 Dec;128(6):1354-5.
Peterson JC, Paget SA, Lachs MS, Reid MC, Charlson ME. The risk of comorbidity. Ann Rheum Dis. 2012 Feb 2.
For more publications, please see the PubMed listing.
Clinical investigation into the pathogenesis and optimal treatment of rheumatoid arthritis, systemic lupus erythematosus, the systemic vasculitides, premature atherosclerosis associated with autoimmune disorders and steroid-induced osteoporosis.
Welcome to our practice. My staff and I are committed to providing you with the best possible rheumatology care anywhere in the setting of a warm, caring, supportive office environment that is aimed at improving the quality of your life. I will share my over 35 years of medical and rheumatology expertise with you, and we will both work toward developing a close partnership that will keep you as healthy as possible, no matter what your current state of health is.
My main aim is to be available for you for any problems that may arise. To this end, I will give you my email address at the end of your first visit because I believe that it is a superb way to communicate. However, for those of you who do not use email, you can contact me via telephone, facsimile, mail or in person.
Please be prepared for your appointment by completing the New Patient Forms (1-5 found below); we ask that you please bring them with you to the appointment filled out and completed. This preparation is necessary so that you can give me the best, most comprehensive, cumulative and up-to-date information about your overall health and your current rheumatologic problem. The better my appreciation of who you are, what your problem is, and how it has affected your life, the better I will be able to help you.
While most doctors are thorough in their discussions with you, it is always a good idea to come prepared for the appointment. You are encouraged to write questions specifically tailored to your concerns prior to arriving at your first appointment. The more in-depth the reporting of your questions, concerns and worries, the better we will be able to find the right answers and bring you back to full health. There is never too much information.
Because your time is as important as mine, we should both run on time. To help improve your experience, we try very hard to run our Practice on schedule. We are unable to do this if you are late. Help us to help you by arriving to your appointment with plenty of time to check in with the receptionist. A nurse will call for you once you’ve checked in to have your vital signs taken before bringing you in to meet with Dr. Paget.
Needed medical records should be requested 7-10 business days prior to the needed date.
Please call the office directly at 212.606.1845 to make an appointment and register. New patient appointments are one hour long and booked in advance. Follow-up visits usually last 15-20 minutes or longer if necessary. Our phone lines are answered by an answering-service from 12:00 – 1:00 p.m. Kindly leave a detailed message and the call will be returned.
If you are unable to attend your appointment which you have booked, please call and cancel within 24 hours so that the appointment can be offered to someone else. Persistent failure to attend the appointments that are booked and excessively cancelled will lead us to consider whether we can continue to reschedule your appointment.
1) New Patient Registration (if prompted to open in Adobe Reader, select Yes)
2) New Rheumatology Patient Questionnaire
3) HAQ Questionnaire
4) Financial Interest Disclosure
5) Medical Release Form
6) Prescription Refill Form
Ms. Monica Lighty – Office Manager
Dr. Paget participates with the following insurance plans:
Aetna - US Healthcare - 4321035 Healthnet - 5C6651 Cigna - 5778331 United HealthCare - 39307 Oxford - NP181 BC/BS - 333211
If you are covered under one of these plans, we will submit the charges for any covered services for you. If you have insurance other than those listed, you still may have coverage subject to the availability of "out of network" benefits. If you are not sure or have additional questions about your coverage, we encourage you to call your insurance carrier. Otherwise, payment is expected at the time of service. As a courtesy to you, our office accepts personal checks, Visa, Master Card, and American Express. Submit your paid receipt to your insurance company and they will reimburse you directly.
Hospital for Special Surgery participates with many insurance plans.
If Dr. Paget does not participate with your particular insurance plan, you still may have coverage subject to the availability of "out-of-network" benefits. Please do not hesitate to contact our office if you have questions regarding your insurance coverage.
Patients with HMO's, please contact your Primary Care Physician (PCP) prior to your visit, to obtain your referral. Please remember, most PCP's are requesting that their patients call at least two weeks in advance for referrals. Dr. Paget is considered a "Specialist". Please bring your referral form with you or have it faxed to us.